| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.4 | 7e-10 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.27 | 2e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 7e-07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-06 |